Psoriasis
Conference Coverage
In psoriasis, is pushing for PASI 90 really worthwhile?
Key clinical point: Psoriasis patients who obtain a PASI 90 response report the quality of life burden imposed by the disease is lifted a full...
Clinical Topics & News
Recent Findings About Cardiovascular Comorbidities
Recent articles in the literature to further the dermatologist’s understanding of the cardiovascular comorbidities in psoriasis patients.
Article
At Last? Apremilast
In late September 2014, the US Food and Drug Administration approved the medication apremilast for treatment of moderate to severe plaque...
News
Biosimilars poised to make biologics more routine
News
Psoriasis severity linked to uncontrolled hypertension
Key clinical point: Patients with moderate to severe psoriasis may benefit from close hypertension management. Major finding: Psoriasis severity...
News
Apremilast improves psoriasis with a side order of weight loss
Key clinical point: Oral apremilast promoted clinically significant weight reduction in addition to clinically meaningful improvement in skin...
Video
VIDEO: Dr. Alan Menter discusses apremilast’s approval for psoriasis
News
High-resolution MRI revealed enthesitis in PsA patients with dactylitis
Key clinical point: High-resolution MRI provided further evidence that enthesitis underlies dactylitis in patients with psoriatic arthritis. Major...
News
Drug combos for psoriatic arthritis upped shingles risk
Key clinical point: Combining TNF-alpha inhibitors with conventional DMARDs more than doubled the risk of shingles in patients with psoriatic...